Combining large-scale proteomic studies with advanced bioinformatics can facilitate the discovery of new protein markers for diagnostic purposes, disease progression markers, molecular targets for drug discovery, disease subpopulations, and risk prediction algorithms. Chris Whelan is trained in neuroscience and statistical genetics. More @Wikipedia
Hover over any link to get a description of the article. Please note that search keywords are sometimes hidden within the full article and don't appear in the description or title.